Claremont Colleges

Scholarship @ Claremont
Scripps Senior Theses

Scripps Student Scholarship

2022

Identification of the Role of swrA in Copper Induced Poly-gammaglutamic Acid Production in Bacillus subtilis
Maya Addison

Follow this and additional works at: https://scholarship.claremont.edu/scripps_theses
Part of the Biology Commons, and the Microbiology Commons

Recommended Citation
Addison, Maya, "Identification of the Role of swrA in Copper Induced Poly-gamma-glutamic Acid
Production in Bacillus subtilis" (2022). Scripps Senior Theses. 1883.
https://scholarship.claremont.edu/scripps_theses/1883

This Open Access Senior Thesis is brought to you for free and open access by the Scripps Student Scholarship at
Scholarship @ Claremont. It has been accepted for inclusion in Scripps Senior Theses by an authorized
administrator of Scholarship @ Claremont. For more information, please contact scholarship@cuc.claremont.edu.

Identification of the Role of swrA in Copper Induced Poly-g-glutamic Acid Production in
Bacillus subtilis

A Thesis Presented
by

Maya Addison

To the Keck Science Department
Of Claremont McKenna, Pitzer, and Scripps Colleges
In partial fulfillment of
The degree of Bachelor of Arts

Senior Thesis in Biology
April 25, 2022

Table of Contents
Table of Contents…………………………………………………………………………….………..2
Abstract…………………………………………………………………………………………………4
Background…………………………………………………………………………………………….4
Post Antibiotic Era…………………………………………………………………………..4
Antimicrobial Properties of Copper……………………………………………………….8
Bacterial Defenses Against Metals……………………………………………………….10
Poly-g-glutamic acid………………………………………………………………………..10
g-PGA synthesis……………………………………………………………………11
pgsbBCAE operon regulates g-PGA……………………………………………………..12

g-PGA production in response to metal toxicity………………………………………..13
swrA………………………………………………………………………………………....13
swrA regulates g-PGA expression in response to copper toxicity…………………..13
Methods……………………………………………………………………………………………..18
Generation of Evolved Strain 14 and Evolved Strain 15 (GJ014 and GJ015)……18
Transformation of NCIB3610 B. subtilis with DswrA………………………………..20
Morphology Assays with Copper (II) Sulfate…………………………………………21
Transformation of NCIB3610DswrA B. subtilis with DppsB……………………….22
Kirby-Bauer Assay……………………………………………………………………….23
Statistics…………………………………………………………………………………...28
Results……………………...................................................................................................28
Discussion………………………………………………………………………………………….27
Conclusion………………………………………………………………………………………. .34

2

Acknowledgements………………………………………………………………………………34
Literature Cited…………………………………………………………………………………36

3

Abstract
Each year over 2.8 million Americans are infected by an antibiotic resistant strain of
bacteria with over 35, 000 dying as a result (CDC). The lack of development of new antibiotics
has renewed interest in the antimicrobial properties of copper. Gram positive bacterium such as
Bacillus subtilis produce poly-gamma-glutamic acid (γ-PGA) to sequester excess copper ions.
swrA has shown to be essential for proper activation of the pgs operon by phosphorylated DegU
via an unknown mechanism. This study seeks to determine the role of swrA in copper induced gPGA production and if swrA and ppsB are involved in copper resistance. Copper Morphology
assays were conducted with ΔswrA, GJ014, GJ015, and 3610 B. subtilis. swrA mutants did not
produce γ-PGA in the presence of copper. Kirby Bauer assays were conducted with ΔswrA,
ΔppsB, ΔswrAΔppsB mutants and 3610 B. subtilis to assess copper resistan
ce There were no significant differences in the average zone of inhibition of all four
strains tested. The results of this study indicate that swrA is essential for copper induced γ-PGA
production. This study also points to a regulatory pleotropic role of swrA of the pgs, fla/che, and
srfA operon via the deg system to allow for continued copper resistance. Further understanding
the role of γ-PGA production will assist in developing future antimicrobials using copper.
Background
The Post Antibiotic Era
In 1928, Sir Alexander Fleming found Penicillium notatum growing on his equipment.
The antimicrobial properties of this fungus would lead to the development of the first modern
antibiotic, Penicillin (Figure 1). Antibiotics are defined as any compound that can inhibit the
growth of another organism . Penicillin opened a new chapter of medicine by providing a new
way to prevent and fight bacterial infections. Before the introduction of modern antibiotics in
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1928, mortality rates for common infections such as pneumonia were as high as 40 percent and
even higher for staph infections at around 80 percent(1). Wound infections were generally
treated with amputations with around 70 percent of amputations in World War I being the result
of wound infections (2). Being able to control infections, such as wound infections, allowed for
advances in medicine such as surgery, organ transplants, dialysis, and cancer treatments (3).
Since the introduction of antibiotics, the average lifespan in the United States has increased from
56.4. years to 80 years which has been attributed to infection control and the mentioned medical
advancements.
Within a decade of Penicillin’s discovery, clinicians identified Penicillin resistant strains of
bacteria (4). In response, researchers developed stronger antibiotics to fight this Penicillin
resistant such as Methicillin which target bacterial cell walls and ; however, resistant strains to
these new antibiotics were found also a decade later (Figure 1). With each introduction of new
antibiotics, resistant strains followed soon after. In 1968, the first case of methicillin-resistant
Staphylococcus aureus (MRSA) in the United States; the rise of MRSA from 1968-1980 alarmed
clinicians as methicillin was a part of the more powerful class of tetracyclines (1, 5). Clinicians
in the 1990s officially defined antibiotic resistance as a phenotypic or genotypic property of
bacteria that allows it to inactivate, block, or exclude the killing or inhibitory effects of
antibiotics (6).

The relatively quick evolution of bacteria is owed to its ability to pass along

genes to other bacteria for resistance through horizontal gene transfer (the ability of bacteria to
pass along its genes to other species of bacteria)(7). Bacteria to quickly develop defenses
against antibiotics has led to a silent epidemic of antibiotic resistance strains of bacteria. In
2019, nearly 80 years after the introduction of modern antibiotics, the Center for the Disease
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Control declared the 21st century as the ‘Post Antibiotic Era’ in response to the continual
increase in resistant strains of bacteria.

Figure 1. Timeline of the development of modern antibiotics and acquired resistance
The CDC in a 2019 report declared the 21st century as the ‘Post Antibiotic Era”(3). The
CDC and World Health Organization warned that this era would be a time where common
infections and minor injuries could result in death (3, 8). This post-apocalyptic warning was
becoming a reality; the report stated that over 2.8 million Americans were infected with an
antibiotic resistant strain of bacteria each year with over 35,000 dying as a result (3). At the same
time, the CDC reported an increase in sepsis – an extreme immune response to an infection that
can result in organ and tissue damage (9, 10) The CDC pointed to this as an example of what a
future without antibiotics may look like. Treatments for sepsis involve high doses of intravenous
antibiotics and surgery to remove damaged and dead tissue (9, 10). With over 1.7 million
Americans developing sepsis each year and over 270,000 dying from the condition, the lives of
many Americans are threatened by the inability to treat this deadly condition(9). Sepsis reveals
one consequence of antibiotic resistance and how reliant modern medicine is on effective
antibiotics. Antibiotic resistance threatens the very foundation of modern medicine; modern
medicine depends on the ability to prevent and counteract bacterial infections. In the case of
surgery, antibiotics are needed to reduce the likelihood of complications of postoperative
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infections. However, it must be noted that antibiotic resistance did not form overnight, and that
the CDC declaration did not arrive without cause. The quick progression of this new era can be
pinpointed to four key factors
A combination of factors are key contributors to this silent epidemic. The potential causes
of the current epidemic all point to an excessive and inappropriate use of antibiotics as the
catalyst for the rise of resistant bacteria (4). One factor is associated with the high usage of
antibiotics in livestock. Nearly 80 percent of antibiotics produced in the United are given to
livestock as a growth supplement (4). Molecular detection has shown that antibiotic use can
make its way to humans through the food supply; bacteria with resistance are able to outcompete
“susceptible” strains of bacteria (4). These bacteria are transferred to humans through meat
products and can multiply and pass resistance through horizontal gene transfer (HGT) (4).
Another factor is the overuse and inappropriate prescribing of antibiotics. Around 30 to 50
percent of prescribed antibiotics are incorrect (4). Inappropriate prescribing gives preexisting
bacteria ample opportunities to increase in virulence and resistance through random mutations
and HGT (4). While misuse plays a big factor, overuse of antibiotics also a play a large role.
Countries outside of the US can have little to no regulation against antibiotic use; some
antibiotics can even be bought over the counter (OTC) (4). The internet has also supplied
another way to obtain antibiotics in countries that do regulate its use (4). Overuse provides
bacteria with the same opportunities for bacteria to develop resistance and pass it to other
bacteria (4, 11). At the same time, overuse also provides an intense selective pressure which
allows bacteria via natural selection to quickly adapt and multiply (11). The final and largest
contributor is the lack of development of new antibiotics in the past two decades. Unlike the
response seen in the 50s and 60s, the continued discovery of antibiotic resistant bacteria has not
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spurred the development of new antibiotics (Figure 1)(1, 4, 5). In the past decade, 15 of the 18
major pharmaceutical companies have abandoned antibiotic development completely (1, 4).
Economists point to the lack of financial incentive towards developing antibiotic therapies;
antibiotics are curative, used for a relative short period of time, and are sold for $1000-$3000
compared to chemotherapy which is priced at $10,000 per treatment (1, 4). The slow
development of new antibiotic therapies also provides pathogenic bacteria with the opportunity
to develop resistance, especially against stronger classes of drugs like Vanamycin. The misuse
and overuse provide the perfect storm for an epidemic of resistant strains; slow drug
development serves as an additional catalyst. Without new antibiotics, and procedures using
modern medical practices depend on infection control and prevention. Antibiotic resistance this
threatened to destroy the very foundation of medicine. To combat antibiotic overuse, misuse,
and slow development, researchers have investigated how early human civilizations prevented
and treated bacterial infections. They that early humans took advantage of the antimicrobial
properties of metals such as copper.
Antimicrobial Properties of Copper
The earliest use of copper can be traced to human civilizations dating back to 5 and 6 BC
(5). The first recorded use of copper in medicine appeared in the Smith Papyrus – an Egyptian
medical text written around 2600 and 2400 BC (7). Egyptian physicians cited copper as a way to
disinfect chest wounds, treat scalds, relieve itching, and purify drinking water (12). On the
Greek island of Cyprus, copper was found in abundance; the Hippocratic Collection (coauthored
by Greek physician Hippocrates), recommended copper to dress wounds and treat leg ulcers (8).
In the 19th and 20th centuries, copper served as a popular antimicrobial to treat common
infections like cholera, syphilis, and tuberculosis until the introduction of commercial antibiotics
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in 1940 (7). One key study in 1983 found brass doorknobs (alloy of copper and zinc) were more
effective in preventing the spread of microbes than plastic or commonly used stainless Steele in
hospitals (13).
Copper is a fascinating trace element that is essential to most living organisms but toxic
in excess due to its high reductive potential. Copper has a redox potential that ranges from +200
to +800 mv allowing it to serve as an electron donor, acceptor, and carrier (5). For instance, the
13 protein cytochrome C oxidase (CCO) contains three copper ions that are essential to its
function; cytochrome C serves as a key electron acceptor in the electron transport chain in
aerobic organisms (ETC) (14). These same However, these same reductive properties of copper
can damage the cellular membranes of pathogenic organisms such as bacteria. Excess copper can
participate in a Fenton-type reaction to generate reactive hydroxyl radicals (7).

𝐶𝑢! + 𝐻" 𝑂" → 𝐶𝑢"! + 𝑂𝐻 # + 𝑂𝐻 !
Schematic 1. Equation for a fenton-type reaction involving copper
Hydrogen peroxide can pass through the cell membrane and when combined with a
reducing agent such as copper, can produce radicals that damage genetic material, cause
oxidation of lipids in the membrane, and inactivate enzymes associated with the cell
membrane of bacteria (15). There is evidence that copper plays an important part of the
innate immune system. During phagocytosis, some cells will accumulate Cu(I) to kill
pathogens (16). Copper also can harm the host’s cell’s too; however, the concentrations of
copper needed to inhibit or destroy pathogenic organisms differs from the cells of the host.
Copper overall serves as a great bactericidal because its high redox potential and ability to
serve as an electron carrier or acceptor.
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Bacterial Defenses Against Metals
Just as bacteria has developed defenses against antibiotics, they have done the same
with metals. Gram-negative bacteria sequester excess copper into the periplasm and bind it to
metallochaperones (17). Gram-positive bacteria (and some gram-negative) use
metallochaperones to buffer Cu(I) to areas of lower concentrations in the cytoplasm of the
cell (14). Bacteria can also form biofilms to protect themselves against metal intoxication.
Biofilms are a cluster of bacteria that are attached to a surface in a matrix. Biofilms allow
bacteria to adapt to their environment by altering their metabolism, gene expression, and
protein production (18). In extreme environmental conditions, biofilms reduce the minimum
cellular conditions needed for the bacteria to survive. To protect themselves from
antimicrobials such as copper, biofilms can contain neutralizing agents or barriers to
counteract metal toxicity. One such compound produced in bacterial biofilms to fight metal
toxicity is poly-g-glutamic acid.
Poly-g-glutamic acid
Poly-g-glutamic acid (g-PGA) is a biodegradable polymer made up of repeating units
of L-glutamic and D-glutamic acids connected by g-amide linkages (Figure 2)(19). g-PGA,
discovered in 1937 in Bacillus subtilis comes in two forms, the a and g, which depends on the
location of the carboxyl group; the g form of the compound is typically found in bacterial
species. This g form prevents the degradation of the compound by proteases in the cell that
cleave a-linkages (19). g-PGA function is highly variable and dependent on if it is released or
bound by peptidoglycan to the bacterium. g-PGA that is released can protect the bacterium from
extreme conditions, while attached g-PGA can help the bacterium evade phage attacks or
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recognition by the immune system (19). Soil bacteria such as B. subtilis can release g-PGA into
the environment to sequester high concentrations of toxic metal ions (19).

Figure 2. Chemical structure of a polymer of g-PGA. Created using Biorender.com
g-PGA synthesis

To develop copper as an antimicrobial and potential antibiotic, the mechanisms of g-PGA
production must be known. Understanding these mechanisms will assist in targeting an important
defense measure taken by gram positive bacteria; targeting this mechanism can improve copper’s
antimicrobial activities. g-PGA production begins with the generation of L-glutamic acid. Lglutamic acid can come from two sources, either through the conversion of carbon using acetylCoA and a-Ketoglutaric acid from the TCA or exogenously and converted to L-glutamine(19).
g-PGA contains a mixture of D and L enantiomers of glutamic acid, using glutamate racemase,
bacteria such as Bacillus subtilis will convert L-glutamic acid to D-glutamic acid (19)L and D
glutamic acids are next involved in a ATP-dependent polymerization reaction. The phosphoryl
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group of ATP is transferred to a terminal group of the carboxyl group via hydrolysis (19). An
amino group on the glutamic acid performs a nucleophilic attack on the phosphorylated carboxyl
group forming an amide linkage (19). Chains of g-PGA are formed with the help of the PgsBCA
synthase complex. The genes pgs operon are involved in the polymerization of released g-PGA
and are the key production machinery of g-PGA in Bacillus.

Figure 3. Overview of g-PGA biosynthesis. Figure generated using BioRender
pgsbBCAE operon regulates g-PGA
Regulation is another component of g-PGA production that is also important in observing
copper’s bacterial fighting abilities by understanding the genes involved in turning on the
machinery responsible for g-PGA synthesis (Figure 3). The production of released g-PGA is
regulated by four identified genes – pgsB, pgsC, pgsA, and pgsE (20). These genes make up the
12

pgs operon which is responsible for polymerizing g-PGA at the active site of the g-PGA
synthase (21). PgsA and PgsE mediate the transport of g-PGA while PgsB and PgsA catalyze the
polymerization of g-PGA via ATPase activity (20). The genes pgdS, cwlO, and ggt are
responsible for g-PGA degradation by encoding components of glutamate dehydrogenase (20).
The pgs operon is regulated by a two component DegS-DegU system and ComP-ComA
quorum sensing system (18). In Bacillus, high cell density will trigger the phosphorylation of
Deg and Com proteins to drive the transcription of pgsBCA (Figure 3). Environmental signals
will first promote phosphorylated ComP to phosphorylate ComA (18). ComA-P activates degQ
transcription (a key regulator) (22). DegQ-P encourages the phosphoryl transfer of the DegS
protein kinase to DegU (23). DegS also has phosphatase activity and can deactivate DegU via
dephosphorylation (21). DegU-P controls the expression of pgsBCA by binding near the
promotor; however, cooperation between DegU-P and SwrA is necessary to full activate
transcription of the pgsBCA operon (24). The direct relationship between DegU-P and SwrA is
unknown but previous work by Stanley and Lazazzera has determined the two proteins are
essential for g-PGA production (25). The regulatory machinery for g-PGA synthesis and
degradation are believed to be involved in the ability for Bacillus bacteria to use g-PGA as a
defensive measure against copper intoxication.
g-PGA production in response to metal toxicity

g-PGA is hypothesized to protect B.subtilis from metal intoxication by sequestering metal
ions (18). Previous work done by Deol et al. demonstrated that B.subtilis exposed to excess
levels of copper and zinc produced a mucoid phenotype which was later identified as g-PGA
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(26). Deol et al. also found that g-PGA protects B. subtilis from zinc and copper intoxication. B.
subtilis mutants with DpgsB (the removal of the pgsB gene involved in activating the pgs operon)
did not produce g-PGA and showed decreased growth when compared to the wild type (26).
However, the results of this study differed from previous literature, as the DdegU mutant still
produced g-PGA in the presence of zinc and copper (26). Additionally, when B. subtilis was
grown at metal concentrations determined to induce g-PGA production, increased pgs and pgdS
promotor activity was not found (26). The authors suggested a potential alternative pathway
with pgsE – the last gene involved in the pgs operon (26). Additional research conducted in the
Chandrangsu Lab by Grace Johnson (unpublished) however pointed to swrA – a gene essential
for g-PGA production – as a key regulator of g-PGA production in response to metal
intoxication. Johnson evolved wild-type Bacillus subtilis (NCIB3610) by exposing the it to
excess concentrations of Cu2+ until resistance appeared. Two resistant strains – GJ014 and GJ015
- were found to not produce g-PGA in the presence of copper and contained dull, flat colony
morphology. Genome sequencing found that these two resistant strains carried mutations in the
genes swrA and ppsB; the mutation found was identified later to encode for a premature stop
codon (Johnson, unpublished). The work by Grace Johnson indicated that swrA and ppsB may
have an essential role in regulating copper induced g-PGA production.
swrA
The swrA gene encodes for a 117 amino acid long protein that cooperatively works with
phosphorylated DegU (DegU-P) to drive pgsBCA expression. swrA is involved in both the
pgsBCA operon and the fla/che operon which regulates B. subtilis swarming motility (24). SwrA
supports DegU-P by stimulating the fla/che promotor to enable swarming and elevating the
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number of flagella present (27). Two studies indicated SwrA is essential for g-PGA production in
B. subtilis. Osera et al. found that SwrA and DegU-P work in a cooperative manner (22). DegUP alone can activate the pgs transcription at a minimal level without swrA expression; however,
overexpression of swrA in a strain with a mutated degU did not activate the pgs operon (24). At
the same time, Oshawa et al. found that high levels of DegU-P could fully activate the pgs
operon in the absence of swrA and the transcription factor degQ minimally but also concluded
that swrA stimulated the DegU-P dependent expression of pgsB for the proper production of gPGA (22). Ermoli et al. indicated that SwrA is a key modulator of DegSU on the pgsB promotor
(19). Wild type DegSHy with mutated swrA did not produce g-PGA; mutated degS (which
encodes for a Kinase that phosphorylates DegU) with mutated swrA also did not produce g-PGA
(21). The mutated degSHy (a Hy mutation was used to cause excess accumulation of DegU-P)
with a functional swrA resulted in the hyperproduction of g-PGA (19). Ermoli et al. concluded
that SwrA is a regulator of the pgsB along with DegU; swrA is needed for sufficient production
of g-PGA (19). While the literature has shown that swrA is needed for g-PGA production, it has
not determined if swrA is essential for copper induced g-PGA production or the relationship
between swrA and ppsB in g-PGA production.
swrA regulates g-PGA expression in response to copper toxicity
This study aims to determine if swrA has a role in regulating g-PGA production in the
presence of excess copper. We will determine if swrA or ppsB cooperatively or independently
regulate g-PGA production. Understanding swrA’s role in g-PGA production in response to metal
toxicity will allow us to further study the anti-microbial properties of copper and the defenses
bacteria develop against it.
15

Additionally, this study will also investigate how ppsB is involved in g-PGA production.
ppsB has not been previously cited to be involved g-PGA production or copper resistance in
Bacillus bacteria. It is known ppsB is one of five genes that encode for plipstatin synthetase.
Plipstatin is one of the three metabolites (in addition to g-PGA) produced by B. subtilis and is
potentially involved in the anti-fungal properties of the bacteria. Surfactin is the third metabolite
produced by B. subtilis that also has antifungal properties. The only association that ppsB shares
with swrA is they are both regulated by deg system through an unknown mechanism (28). This
project seeks to understand the potential relationship between swrA and ppsB in copper induced
g-PGA production and resistance. Understanding the roles of these two genes will further clarify
the genes and proteins necessary for copper induced g-PGA production and how it is regulated
We used the model organism, Bacillus subtilis to observe g-PGA production. B. subtilis is
a gram-positive soil bacteria that is utilized in industry for its excellent secretion ability(29). B.
subtilis is a great model organism because it has a fermentation cycle of four hours, genetic
stability, no strong codon expression, and a vast database of well-known and developed genetic
tools and knockouts (19, 30) The two main strains of B. subtilis used are NCIB3610
(undomesticated Bacillus) and NCIB168 (domesticated Bacillus). The laboratory strain,
NCIB168, has lost the ability to produce g-PGA; however, NCIB3610, a derivative of the
Marburg line, is a lab strain that can produce g-PGA (19).
NCIB3610 B. subtilis was transformed with a DswrA from NCIB168 from the Bacillus
Genomic Stock Center (BSGC). The transformed NCIB3610 withDswrA was exposed to
increasing levels of copper to determine if swrA is needed g-PGA production in response to
copper toxicity. Colony morphology assays were performed to assess the g-PGA production and
16

colony appearance. NCIB3610 DswrA was compared to two evolved strains of B. subtilis, GJ014
and GJ015, that were shown to have mutations in swrA and ppsB. GJ014 and GJ015 colonies
were observed to have irregular edges, undulate margins and a flat, large appearance. We
hypothesized that swrA is involved in g-PGA production in B. subtilis in response to copper
intoxication. We predict that the NCIB3610 strain with the swrA knockout will not produce gPGA in the presence of copper. The colonies will appear irregular in shape, with undulate
margins and flat in appearance. The lack of g-PGA production in NCIB3610 DswrA points to
swrA playing an important role in regulating g-PGA secretion in response to copper.
We performed Kirby-Bauer assays to assess the role of swrA and ppsB in copper
resistance in B. subtilis. Kirby-Bauer assays assess how resistant a bacterium is to an antibiotic,
in this experiment, the assay was used to assess copper resistance. We generated a double mutant
of swrA and ppsB by transforming the NCIB3610DswrA with NCIB3610DppsB. NCIB3610,
NCIB3610DswrA, NCIB3610DppsB, and NCIBDswrADppsB were incubated in 0.75% Luria
Broth (LB) agar and poured onto a solid 1.5% LB agar plate. A disk was be saturated with 1M
copper (II) sulfate and allowed to diffuse overnight. We assessed resistance by measuring the
zone of inhibition of each strain. The zone of inhibition occurs around the saturated disk where
the most copper is present and where the most bacterial die off should occur. Bacterial strains
that are more resistant have smaller zones of inhibition. We hypothesized that strains with the
swrA knockout will be less resistant to copper intoxication because swrA has a potential
regulatory role in g-PGA production and copper resistance. From the disk diffusion assays, we
can determine if ppsB and swrA work together or separately in helping B. subtilis resist copper
intoxication. We predict that NCIB3610DswrA will have a larger zone of inhibition than the
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wild type if swrA is involved in copper resistance. The same can be said of NCIB3610DppsB.
We will use a double mutant to identify if swrA and ppsB are involved in a potential pathway
involved in g-PGA production. We predict that is swrA and ppsB work together, the zone of
inhibition will be larger than the other three strains tested.
Overall, this study will identify the if swrA is involved copper induced g-PGA production
in B. subtilis. At the same time, the results of this study will determine if swrA or ppsB is
responsible for the copper resistance seen in the evolution studies by Grace Johnson. Identifying
the genes involved in copper resistance in B. subtilis can provide further insight into how
bacteria protect themselves from metals. Antibiotic resistance is a serious threat to our healthcare
system and modern medical practices. Identifying the genes involved in bacterial defenses
against metals, such as g-PGA, will allow for treatments involving metals to be developed. These
treatments could target the machinery of these bacteria and allow for treatments in the futures
using metals combat the future to combat antibiotic resistant strains of bacteria.
Methods
Generation of Evolved Strain 14 and Evolved Strain 15 (GJ014 and GJ015). The
evolved strains were obtained from research conducted by Grace Johnson. The methods outlined
below are from her research conducted this summer. To identify potential genes involved in
copper resistance and g-PGA production, wild type of B. subtilis was exposed to increasing
concentrations of Cu2+ to generate resistant strains. Colonies 3610 B. subtilis were streaked onto
solid 1.5% LB agar plates and incubated overnight at 37°C (Table 1). Colonies were selected
from the solid LB agar plates and inoculated in LB media containing Cu2+ at concentrations
ranging from 0mM to 2mM. These cultures were incubated overnight at 37°C with shaking
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(200rpm) or until a OD600~0.6 was obtained. 3610 was grown again in 1mM Cu2+ LB medium
and incubated at 37°C. This same culture was removed and placed into another 1mM Cu2+LB
media again with the same conditions to place additional stress on the bacteria. A 1:100 dilution
of the overnight culture was placed into a 1.5mM Cu2+ LB media and incubated overnight at
37°C with shaking (200rpm). This culture was plated onto a solid 1.5% LB agar plate, incubated
overnight at 37°C, and selected for colonies based on their morphologies. Evolved strains 14 and
15 (GJ014 and GJ015) were shown to form flat, large, and matte colonies. These colonies did not
produce g-PGA. DNA sequencing revealed these strains contained mutations in swrA and ppsB.

19

Table 1. B. subtilis strain features and associated phenotypes
Transformation of NCIB3610 B. subtilis with DswrA. To assess the importance of

DswrA importance in g-PGA production in the presence of copper NCIB3610 was transformed
with DswrA with an erythromycin marker from NCIB168DswrA::erythromycin from the BSGC
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(31). NCIB168 B. subtilis does not produce g-PGA. To mitigate this problem, DswrA was
transformed into the NCIB3610 B. subtilis strain (undomesticated) (Table 1). The
transformation method outlined in Kunst et al. using a single crossover event was used (34).
NCIB3610 and NCIB168DswrA::erm were streaked and incubated at 37°C overnight on
solid 1.5% LB agar and LB agar with erythromycin. MC media was developed using 1M
potassium phosphate buffer, 1M Trisodium citrate, 1M MgSO4, 50% glucose, 10% Casein
hydrolysate, 50% potassium glutamate, 22mg/mL ferrous ammonium citrate, and 2 mg/mL
tryptophan (31). The MC media was used for liquid cultures the next day as a starvation agent.
The following morning, the recipient strain (NCIB3610) and donor strain (NCIB168DswrA) were
inoculated in MC media. Both strains were incubated at 37°C with shaking at 200 rpm overnight.
A 1:100 dilution of the recipient strain was created and incubated at 37°C with shaking
(200 rpm) until an OD600 ~ 0.6-0.8 was reached. The donor strain was filter sterilized using a
syringe filter. The filtrate contained DNA from the lysed cells. Donor filtrate was mixed with
the recipient strain and incubated at 37°C with shaking (200 rpm) for two hours. The donor
filtrate-recipient media was transferred into an Eppendorf tube and centrifuged at 5000 rpm for 5
minutes to pellet the cells. The supernatant was removed with 100 µL of supernatant remaining
to resuspend the pellet. The pellet was plated and smeared onto a solid 1.5% LB agar plate with
erythromycin to assess success of the transformation. The transformed NCIB3610
(NCIB3610DswrA) was incubated overnight at 37°C (Table 1).
Morphology Assays with Copper (II)Sulfate. Copper morphology assays were
conducted to assess if DswrA contributes to g-PGA production when exposed to excess levels
Cu2+. NCIB3610, GJ014, and GJ015 were streaked onto separate 1.5% LB agar plates while
NCIB3610DswrA was streaked on 1.5% LB agar with erythromycin. All the plate were incubated
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overnight at 37°C. A colony from each plate was inoculated into four separate tubes with 1.5%
LB media and incubated overnight at 37°C with shaking (200 rpm) until an OD600 ~ 0.4-0.6 was
reached.
Solid 1.5% LB agar plates were prepared with 0mM, 1mM, 2mM, and 3mM of CuSO4.
A 1:100 dilution of the four overnight cultures was prepared with 1.5% LB liquid media and
again incubated at 37°C with shaking (200rpm) for 3-5 hours or until an OD600 ~ 0.6-0.8 was
reached. The LB agar and copper plates were divided with four quadrants and labeled. A 5 µL
dot of each diluted culture was micro pipetted onto the appropriate quadrant on all four
concentrations of CuSO4. The four plates of LB agar and copper sulfate were incubated
overnight at 37°C and analyzed for growth.
Transformation of NCIB3610DswrA B. subtilis with DppsB. A double mutant of the
transformed NCIB3610DswrA B. subtilis (recipient) was generated to determine if swrA or ppsB
are responsible for copper resistance and g-PGA production. NCIB3610DppsB::kan served as
the donor in this transformation. The MC media and methods outlined in Kunst et al. were used
in this transformation (citation needed).
The NCIB3610DswrA and NCIB3610DppsB B. subtilis strains were prepared using the
transformation written above. A 1:100 dilution of the recipient strain was performed with MC
media and incubated at 37°C with shaking (200 rpm) until an OD600~0.6-0.8 was obtained. The
donor strain was filter sterilized with a syringe filter and mixed with the diluted recipient media.
This mixture was transferred to an Eppendorf tub and centrifuged at 5000 rpm for 5 minutes.
Part of the supernatant was removed with some remaining to resuspend the pellet. The pellet was
plated on a solid 1.5% LB agar with kanamycin to determine if the DppsB had been successfully
transformed into the NCIB3610DswrA.
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Kirby-Bauer Assay. Diffusion discs assays were performed to assess the role of swrA
and ppsB in copper resistance (Figure 4). NCIB3610, NCIB3610DswrA, NCIB3610DppsB, and
NCIB3610DswrADppsB were streaked and incubated overnight on solid 1.5% LB agar plates and
their corresponding antibiotic. The four strains were inoculated in 10 mL of LB and incubated
overnight at 37°C with shaking (200 rpm) or until an OD600 > 0.6 was met. The overnight
cultures were diluted (1:100) with 5 mL of 0.75% LB agar and placed on a heat block at 60°C to
prevent the agar from resolidifying.
Four 1.5% LB agar plates were prepared and brought to room temperature. The
overnight cultures were poured evenly across the surface of the 1.5% LB agar plate and allowed
to solidify. Once solidified, sterilized filter discs were placed in the center of the plate. A 5µL
drop of 1M copper sulfate was micropipetted onto the disk. The plates were incubated overnight
at 37°C. The zone of inhibition of each strain was measured the following morning.

Figure 4. Kirby-Bauer assays were conducted to determine if swrA and ppsB contribute to
copper resistance in B. subtilis. This figure was created using Biorender.com
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Statistics. A One-Way ANOVA was used to analyze the average zone of inhibition from
the disc diffusion assay. Due to the small sample size, normality was assessed in the residuals of
the dataset overall than within each mutant group. A Shapiro Wilk Test of normality was
conducted and showed the residuals of the data set were normally distributed (W=0.86, p=0.02).
A Levene’s test demonstrated that the zone of inhibition data did possess homogenous variances
(df=3, F=1.42, p=0.29). The requirements of a parametric One-Way ANOVA were met.
Results
B. subtilis strains with swrA mutations are shown to not produce g-PGA when exposed to
varying concentrations of copper.
We performed copper morphology assays to determine if swrA has a role in g-PGA
production in response to copper intoxication. We transformed a undomesticated lab strain of B.
subtilis (NCIB3610) with a swrA knockout (DswrA) and plated on varying concentrations of
copper sulfate. The two evolved strains, GJ014 and GJ015, were used as a reference as these
strains contained mutations in ppsB and swrA along with NCIB3610 which is known to produce
g-PGA in response to metal toxicity. The four strains were all plated on 1.5% solid LB agar with
0mM, 1mM, 2mM, and 3mM of copper sulfate, incubated overnight, and assessed for g-PGA
production. B. subtilis strains containing mutated swrA did not produce g-PGA at all
concentrations of copper sulfate (Figure 5). At 1mM and 2mM, the production of g-PGA is seen
with NCIB3610; the colony contains a shiny appearance and is round (Figure 5). At 0mM the
most growth is seen in all strains (Figure 5). GJ014, GJ015, DswrA formed a matte colony with
irregular edges at 0mM and 1mM. The DswrA colony formed at 2mM resembled NCIB3610 with
round edges and small when compared to GJ014 and GJ015; however, no g-PGA production is
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present (Figure 5). At 3mM, no growth occurred in GJ015 and NCIB3610 while minimal
growth is seen in DswrA and GJ014. The copper morphology assays may demonstrate that swrA
has a role in g-PGA production in response to excess copper.

Figure 5. Colony morphology assays on 1.5% LB agar plates with 0mM, 1mM, 2mM, 3mM of
copper sulfate. Refer to table 1 in methods for strain descriptions
B. subtilis strains with DswrA and DppsB knockouts showed no difference in resistance to excess
copper when compared to the wild type and the double mutant
Kirby-Bauer assays were conducted to test determine if swrA or ppsB contribute to
copper resistance in B. subtilis. A double mutant was generated by transforming
NCIB3610DswrA with NCIB3610DppsB. Sequencing results revealed that GJ014 and GJ015
contained mutations in both ppsB and swrA. The strains 3610, DswrA, DppsB, and DswrADppsB
were inoculated into liquid cultures and incubated overnight at 37.1°C with shaking. The liquid
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cultures were diluted with 0.75% LB agar and placed in a heat block at 60°C. The 0.75% LB
agar solutions were poured onto 1.5% LB agar plates. A disk was placed in the center and soaked
with 1M copper (II) sulfate. All strains were incubated for 24 hours at 37.1°C with the coppersoaked disk diffusing. The diameter of bacterial die off around the disc – the zone of inhibition was measured with a ruler.
Copper diffusion was present in all four plates. 3610 had additional colonies form on top
of the agar and g-PGA production on the outer boundary of the zone of inhibition (Figure 6). No
g-PGA production was viewed on the other strains (Figure 7). Bacterial die off in DppsB mainly
concentrated to the center of the plate compared to the other strains where die off appeared as a
gradient among the halo (Figure 7).
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Figure 7. Kirby-Bauer resistance assays on 1.5% LB agar and diluted cultures in 0.75% LB agar
poured on top. The disk at the center contains 1M of copper (II) sulfate. Refer to Table 1 in
methods for strain descriptions
A One-Way ANOVA was conducted to compare the average zone of inhibition in D
swrA, DppsB, DswrADppsB, and 3610. There were no significant differences in the average zone
of inhibition between all four strains of B. subtilis (Figure 8)
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Figure 8. Bar graph of the average zone of inhibition of 3610, DswrA, DppsB, and
DswrADppsB (mm) with standard deviation (F=0.412, df=3, p=0.747).
Discussion
swrA is involved in copper induced g-PGA production
B. subtilis strains with mutated swrA did not produce g-PGA when exposed to 0mM,
1mM, 2mM, and 3mM of copper (II) sulfate (Figure 5). The wild type displayed a mucoid
phenotype which has shown to be g-PGA when exposed to copper (26). The lack of γ-PGA
production in these mutated strands follows previous literature that found that swrA is essential
for effective g-PGA production. SwrA has been shown to work cooperatively with the
transcription factor DegU in activating the pgs operon (24). The mechanism of how SwrA
cooperatively works with DegU-P to induce the pgs operon is unknown. Excess phosphorylated

28

DegU can overcome the loss of SwrA but does not restore g-PGA production abilities in B.
subtilis (24). SwrA may strengthen the binding phosphorylated DegU to pgsB to activate
transcription pgs operon. Additionally, SwrA may assist in binding by orienting DegU to
properly bind with pgsB (24). Additional studies are needed to determine the exact interaction of
SwrA with DegU.
swrA and ppsB are not involved in copper resistance when compared to the wild type B. subtilis
g-PGA has been found to defend soil bacteria such as B. subtilis from metal intoxication
by sequestering metal ions (32). The free carboxyl groups in g-PGA form complexes with free
metals to absorb metal ions from the soil in B. subtilis (33). Because we identified swrA involved
in copper induced g-PGA production, we conducted Kirby-Bauer assays to assess if it also had a
role in copper resistance. We sought to understand if swrA or ppsB were responsible for any
observed resistance to copper. swrA and ppsB were both identified in GJ014 and GJ015 B.
subtilis strains (Table 1). These strains did not produce g-PGA when exposed to copper. The
Kirby-Bauer assays indicated that swrA and ppsB may not be involved in copper resistance in B.
subtilis.
We first investigated the role of growth medium on B. subtilis growth. B. subtilis can
effectively grow on solid agar and liquid media (34). Solid and liquid mediums require B.
subtilis to engage in different lifestyles. As shown in figure 5, B. subtilis will develop robust
biofilms to protect against copper intoxication. Biofilm production occurs in both media types;
however, how the biofilms form differs. In solid agar plates, biofilms grow and thicken away
from the place of inoculation due to an osmotic pressure gradient from the agar below(34). In
liquid media, biofilms form as a pellicle that initially grow in a thin layer on interface (34)
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Biofilms developed on agar are unable to penetrate the substrate below the interface; however, in
liquid medias, B. subtilis can swim to the media underneath (34).
Kirby Bauer assays are conducted using solid plates with a disc diffusing highly
concentrated copper (II) sulfate (Figure 7). The lifestyle requirements for B. subtilis to survive
on solid media may not be conducive for resisting copper intoxication. A Minimum Inhibitory
Concentration (MIC) assay could better assess copper resistance in B. subtilis. MIC assays are
conducted similarly to Kirby-Bauer assays but done in a liquid solution; the assays determine the
minimum concentration of antibiotic needed to reduce bacterial growth (35) An MIC assay
would rule out if the biofilms formed in liquid media are more effective in resisting copper
intoxication. Additionally, we can rule out if the type of assay contributed to the results seen in
this study.
We also investigated other methods B. subtilis can protect itself against metal
intoxication. SwrA is a master regulator of two operons, the fla/che operon for movement and
pgs operon for g-PGA production. SwrA regulates both operons via the Deg system (Figure 3).
Because we did not see significant differences in the average zone of inhibitions in swrA, ppsB,
and DswrADppsB, we took a closer look into the Deg system. DegQ serves as a pleiotropic
regulator by promoting the phosphorylation of DegS and DegU. Previous literature has shown
that degQ and degU expression may influence srfA expression (36). Miras et al. found that
reduced expression of degQ and degU led to the derepression of the srfA operon prompting
surfactin production. Surfactin is a cyclic lipopeptide produced by B. subtilis (37). It is a member
of a class of molecules called biosurfactants – amphillic compounds made of hydrophilic and
hydrophobic components (Figure 9) (37). Biosurfactants like surfactin can reduce surface
tension to allow for swimming motility (38) Additionally surfactin has shown to be effective in
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bioremediation of soils contaminated with copper sequestering excess copper similar like g-PGA
(39).

Figure 9. Chemical structure of surfactin from B. subtilis. Adapted from Henkel and
Hausmann 2019

Our results may indicate that the reduced expression of the deg system may have led to
the derepression of the srfA operon leading to the production of surfactin (Figure 9). The loss of
swrA showed no effect on B. subtilis ability to resist copper intoxication; however, no g-PGA
was produced (Figure 4). The loss of g-PGA production in the DswrA mutant indicates that swrA
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plays a role in pgs activation. swrA works with the Deg system to regulate the fla/che operon for
motility and g-PGA production. It was previously shown that even with phosphorylated DegU,
swrA expression was still needed to effectively produce g-PGA. The interaction between SwrA
and DegQSU is unknown. Our results may indicate that swrA is a pleiotropic regulator of the pgs
and srfA operon through the deg system. The loss of swrA expression could lead to the reduced
expression of degQSU through some unknown mechanism (Figure 10). Reduced expression of
the DegQSU system causes repression of the pgs operon and activation of the srfA operon
through an unknown mechanism. Activation of srfA operon would induce surfactin production to
maintain copper homeostasis in the event of excess copper exposure.
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Figure 10. Schematic of the pleiotropic regulatory role of swrA in copper resistance
Surfactin, like g-PGA, could help B. subtilis resist excess levels of copper. Future
experiments could expose DswrADdegU and DswrADdegQ double mutants to excess levels of
copper. MIC or Kirby Bauer assays could be conducted to assess resistance to copper. Decreased
resistance could indicate that swrA pleiotropically regulates pgs or srfA through the deg system.
With this information, we can further understand the defenses bacteria such as B. subtilis use to
resist metal intoxication.
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Conclusion
The continued rise of antibiotic resistant superbugs brought a renewed interest in the
antimicrobial properties of metals such as copper. This study demonstrated that swrA is involved
in copper induced ã-PGA production and could potentially serve as a pleiotropic regulator of ãPGA and surfactin production. Future experiments could test swrA, degQ and degU knockouts
against excess levels of copper. These experiments could determine if swrA is a master regulator
of the pgs and srfA operons which both produce compounds that allow B. subtilis to maintain
metal homeostasis by sequestering excess copper. Understanding swrA’s role as a potential
pleiotropic regulator can help us better understand the defenses bacteria employ to resist metal
intoxication. Copper has shown to be an excellent antimicrobial due to its high reductive
potential. Treatments in the future can utilize the antimicrobial properties of copper while
targeting the defense mechanisms bacteria have developed against metal intoxication. The
continued rise of antibiotic resistant bacteria has defined the 21st century as the “Post Antibiotic
Era. ” With an estimated 35,000 Americans dying from antibiotic resistant bacterial functions
each year and the lack of development of new antibiotics, further inquiry into copper and
bacterial defenses against it are essential in protecting and maintaining the very foundation of
modern medicine.
Acknowledgments
I would like to thank Dr. Pete Chandrangsu for his guidance, expertise, and tremendous
support of this project. I also would like to thank Dr. Sarah Budischak for her feedback and
additional guidance. I also thank my lab partner, Grace Johnson (CMC’22), for her assistance in
this project and the opportunity to expand on her summer research. I thank all the members of
the Chandrangsu lab for their feedback. I thank my parents, Clyde and Julie Addison, for their

34

continued support and encouragement during this process. I also want to thank my two dogs,
Marlee and Nova, providing me with happy distractions and support. I want to specifically thank
Marlee for being my study buddy for the past two years. Lastly, I would like to thank the W.M.
Keck Science Center for providing me the opportunity to take on this project.

35

Literature Cited
1. Piddock LJ. 2012. The crisis of no new antibiotics—what is the way forward? The Lancet
Infectious Diseases 12:249–253.
2. Friedman ND, Temkin E, Carmeli Y. 2016. The negative impact of antibiotic resistance.
Clinical Microbiology and Infection 22:416–422.
3. CDC. 2021. Antibiotic-resistant Germs: New Threats. Centers for Disease Control and
Prevention. https://www.cdc.gov/drugresistance/biggest-threats.html. Retrieved 9 December
2021.
4. Ventola CL. 2015. The Antibiotic Resistance Crisis. P T 40:277–283.
5. Grass G, Rensing C, Solioz M. 2011. Metallic Copper as an Antimicrobial Surface. Applied
and Environmental Microbiology 77:1541–1547.
6. Davison HC, Woolhouse MEJ, Low JC. 2000. What is antibiotic resistance and how can we
measure it? Trends in Microbiology 8:554–559.
7. MacLean C, San Millan A. 2019. The evolution of antibiotic resistance. Science Magazine
365:1082–1083.
8. Reardon S. 2014. WHO warns against “post-antibiotic” era. Nature
https://doi.org/10.1038/nature.2014.15135.
9. CDC. 2021. Sepsis is a medical emergency. ACT FAST. Centers for Disease Control and
Prevention. https://www.cdc.gov/sepsis/what-is-sepsis.html. Retrieved 17 March 2022.

36

10. Pradipta IS, Sodik DC, Lestari K, Parwati I, Halimah E, Diantini A, Abdulah R. 2013.
Antibiotic Resistance in Sepsis Patients: Evaluation and Recommendation of Antibiotic Use.
N Am J Med Sci 5:344–352.
11. Sengupta S, Chattopadhyay MK, Grossart H-P. 2013. The multifaceted roles of antibiotics
and antibiotic resistance in nature. Front Microbiol 4:47.
12. Arendsen LP, Thakar R, Sultan AH. 2019. The Use of Copper as an Antimicrobial Agent in
Health Care, Including Obstetrics and Gynecology. Clin Microbiol Rev 32:e00125-18.
13. Kuhn PJ. 1983. Doorknobs: a source of nosocomial infection? Diagnostic Medicine.
14. Collins J. 2017. Copper: Basic Physiological and Nutritional Aspects, p. 69–81. In
Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals. Elsevier.
15. Florence TM. 1995. The role of free radicals in disease*. Australian and New Zealand
Journal of Ophthalmology 23:3–7.
16. Djoko KY, Ong CY, Walker MJ, McEwan AG. 2015. The Role of Copper and Zinc Toxicity
in Innate Immune Defense against Bacterial Pathogens. J Biol Chem 290:18954–18961.
17. Braymer J, Giedroc D. 2014. Recent developments in copper and zinc homeostasis in
bacterial pathogens. Current Opinion in Chemical Biology 19:59–66.
18. Vestby LK, Grønseth T, Simm R, Nesse LL. 2020. Bacterial Biofilm and its Role in the
Pathogenesis of Disease. Antibiotics (Basel) 9:59.
19. Ogunleye A, Bhat A, Irorere VU, Hill D, Williams C, Radecka I. 2015. Poly-γ-glutamic acid:
production, properties and applications. Microbiology (Reading) 161:1–17.
37

20. Hsueh Y-H, Huang K-Y, Kunene SC, Lee T-Y. 2017. Poly-γ-glutamic Acid Synthesis, Gene
Regulation, Phylogenetic Relationships, and Role in Fermentation. Int J Mol Sci 18:2644.
21. Ermoli F, Bontà V, Vitali G, Calvio C. 2021. SwrA as global modulator of the twocomponent system DegSU in Bacillus subtilis. Research in Microbiology 172:103877.
22. Ohsawa T, Tsukahara K, Ogura M. 2009. Bacillus subtilis response regulator DegU is a
direct activator of pgsB transcription involved in gamma-poly-glutamic acid synthesis.
Biosci Biotechnol Biochem 73:2096–2102.
23. Dahl MK, Msadek T, Kunst F, Rapoport G. 1992. The phosphorylation state of the DegU
response regulator acts as a molecular switch allowing either degradative enzyme synthesis
or expression of genetic competence in Bacillus subtilis. J Biol Chem 267:14509–14514.
24. Osera C, Amati G, Calvio C, Galizzi A 2009. SwrAA activates poly-γ-glutamate synthesis in
addition to swarming in Bacillus subtilis. Microbiology 155:2282–2287.
25. Stanley NR, Lazazzera BA. 2005. Defining the genetic differences between wild and
domestic strains of Bacillus subtilis that affect poly-gamma-dl-glutamic acid production and
biofilm formation. Mol Microbiol 57:1143–1158.
26. Deol R, Louis A, Glazer HL, Hosseinion W, Bagley A, Chandrangsu P. 2022. Poly-GammaGlutamic Acid Secretion Protects Bacillus subtilis from Zinc and Copper Intoxication.
Microbiol Spectr e0132921.
27. Calvio C, Osera C, Amati G, Galizzi A. 2008. Autoregulation of swrAA and Motility in
Bacillus subtilis. J Bacteriol 190:5720–5728.

38

28. Tsuge K, Ano T, Hirai M, Nakamura Y, Shoda M. 1999. The Genes degQ, pps, and lpa8(sfp) Are Responsible for Conversion of Bacillus subtilis 168 to Plipastatin Production.
Antimicrobial Agents and Chemotherapy 43:2183–2192.
29. Su Y, Liu C, Fang H, Zhang D. 2020. Bacillus subtilis: a universal cell factory for industry,
agriculture, biomaterials and medicine. Microbial Cell Factories 19:1–12.
30. Koo B-M, Kritikos G, Farelli JD, Todor H, Tong K, Kimsey H, Wapinski I, Galardini M,
Cabal A, Peters JM, Hachmann A-B, Rudner DZ, Allen KN, Typas A, Gross CA. 2017.
Construction and Analysis of Two Genome-scale Deletion Libraries for Bacillus subtilis.
Cell Syst 4:291-305.e7.
31. Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG,
Bessières P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC,
Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi S-K, Codani J-J,
Connerton IF, Cummings NJ, Daniel RA, Denizot F, Devine KM, Düsterhöft A, Ehrlich SD,
Emmerson PT, Entian KD, Errington J, Fabret C, Ferrari E, Foulger D, Fritz C, Fujita M,
Fujita Y, Fuma S, Galizzi A, Galleron N, Ghim S-Y, Glaser P, Goffeau A, Golightly EJ,
Grandi G, Guiseppi G, Guy BJ, Haga K, Haiech J, Harwood CR, Hénaut A, Hilbert H,
Holsappel S, Hosono S, Hullo M-F, Itaya M, Jones L, Joris B, Karamata D, Kasahara Y,
Klaerr-Blanchard M, Klein C, Kobayashi Y, Koetter P, Koningstein G, Krogh S, Kumano M,
Kurita K, Lapidus A, Lardinois S, Lauber J, Lazarevic V, Lee S-M, Levine A, Liu H,
Masuda S, Mauël C, Médigue C, Medina N, Mellado RP, Mizuno M, Moestl D, Nakai S,
Noback M, Noone D, O’Reilly M, Ogawa K, Ogiwara A, Oudega B, Park S-H, Parro V,
Pohl TM, Portetelle D, Porwollik S, Prescott AM, Presecan E, Pujic P, Purnelle B, Rapoport

39

G, Rey M, Reynolds S, Rieger M, Rivolta C, Rocha E, Roche B, Rose M, Sadaie Y, Sato T,
Scanlan E, Schleich S, Schroeter R, Scoffone F, Sekiguchi J, Sekowska A, Seror SJ, Serror
P, Shin B-S, Soldo B, Sorokin A, Tacconi E, Takagi T, Takahashi H, Takemaru K, Takeuchi
M, Tamakoshi A, Tanaka T, Terpstra P, Tognoni A, Tosato V, Uchiyama S, Vandenbol M,
Vannier F, Vassarotti A, Viari A, Wambutt R, Wedler E, Wedler H, Weitzenegger T,
Winters P, Wipat A, Yamamoto H, Yamane K, Yasumoto K, Yata K, Yoshida K, Yoshikawa
H-F, Zumstein E, Yoshikawa H, Danchin A. 1997. The complete genome sequence of the
Gram-positive bacterium Bacillus subtilis. Nature 390:249–256.
32. Candela T, Fouet A. 2006. Poly-gamma-glutamate in bacteria. Molecular Microbiology
60:1091–1098.
33. Yang M, Ferrari E, Chen E, Henner DJ. 1986. Identification of the pleiotropic sacQ gene of
Bacillus subtilis. J Bacteriol 166:113–119.
34. Lee LM, Rosenberg G, Rubinstein SM. 2019. A Sequence of Developmental Events Occurs
Underneath Growing Bacillus subtilis Pellicles. Frontiers in Microbiology 10.
35. Minimum Inhibitory Concentration (MIC) Testing. Microbiology and Cell Biology,
Medicinal Chemistry - Emery Pharma. https://emerypharma.com/biology/minimuminhibitory-concentration/. Retrieved 14 April 2022.
36. Miras M, Dubnau D. 2016. A DegU-P and DegQ-Dependent Regulatory Pathway for the Kstate in Bacillus subtilis. Front Microbiol 7:1868.
37. Rahman FB, Sarkar B, Moni R, Rahman MS. 2021. Molecular genetics of surfactin and its
effects on different sub-populations of Bacillus subtilis. Biotechnol Rep (Amst) 32:e00686.

40

38. Fall R, Kearns DB, Nguyen T. 2006. A defined medium to investigate sliding motility in a
Bacillus subtilis flagella-less mutant. BMC Microbiology 6:31.
39. Ayangbenro AS, Babalola OO. 2018. Metal(loid) Bioremediation: Strategies Employed by
Microbial Polymers. 9. Sustainability 10:3028.

41

